RxDoctor Payments Data

Joseph Zangara, MD

Gastroenterology · Wayne, NJNPI 1447240254

Payments from drug & device makers

$4,329in general payments, 2019–2025

Across 335 payments — averaging $12.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Johnson & Johnson$260
  • Pfizer$206
  • Aimmune Therapeutics, Inc.$190
  • Merck$166
  • plus $870 from 19 others

What the payments were for

  • Food & beverage$4,316100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,329 in reported general payments places this provider in the 65th percentile of 701 gastroenterology providers in New Jersey.

See all gastroenterology providers in New Jersey

Medicare billing

Part B allowed, 2024
$252,894
Medicare patients
690
Services billed
2,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase27$79,631
XifaxanRifaximin20$43,895
TrulancePlecanatide31$23,425
Mesalamine34$21,864
ZenpepLipase/Protease/Amylase13$13,829
LinzessLinaclotide16$11,410
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates84$5,331
Famotidine311$5,134
Dexlansoprazole DrDexlansoprazole14$3,941
Pantoprazole Sodium218$3,448
SutabSod Sulf/Pot Chloride/Mag Sulf19$3,036
Mesalamine ErMesalamine16$2,700
Omeprazole169$2,417
ClenpiqSod Picosulf/Mag Ox/Citric Ac14$2,404
CholestyramineCholestyramine (With Sugar)20$1,467

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,599$91,04143 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$1,038$67,32051 claims
Aimmune Therapeutics, Inc.Zenpep$190$13,82913 claims
Braintree Laboratories, Inc.Sutab$17$3,03619 claims
Ferring Pharmaceuticals Inc.Clenpiq$45$2,40414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 701 gastroenterology providers in New Jersey.

Other gastroenterology in Wayne

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →